This scientist power-couple who recently became billionaires is the driving force behind BioNtech/Pfizer's new Covid-19 vaccine.
Stock experts had earlier anticipated that Pfizer would earn $12.7 billion from its COVID-19 vaccines sales in 2021.
BioNTech has said that its vaccine could work on new Coronavirus strain which was found in the UK.
The distribution of Pfizer's COVID-19 vaccine has commenced across the United States.
The UK government is set to approve the COVID-19 vaccine developed by BioNTech SE and Pfizer Inc next week.
The EU is making plans to buy 300 million doses of BioNTech-Pfizer’s COVID-19 vaccine.
Pfizer Inc could have a COVID-19 vaccine available in the world's largest economy by the end of 2020.
The drugmakers hope to get to the initial target figure of 30,000 participants for the vaccine trial.
Moderna has already begun experimental testing on humans.
WHO has been working to expand access to potential vaccines and scale up production capacity.